The role of the BH3-only protein Noxa in bone homeostasis

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 620-625

  Idrus, Erik ^a   Nakashima, Tomoki ^a,b   Wang, Ling ^a   Hayashi, Mikihito ^a,b   Okamoto, Kazuo ^a,b   Kodama, Tatsuhiko ^c   Tanaka, Nobuyuki ^d   Taniguchi, Tadatsugu ^e   Takayanagi, Hiroshi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Bcl 2 family proteins; Noxa; Osteoclast

Indexed keywords

ADENOVIRUS VECTOR; BH3 PROTEIN; PROTEIN BCL 2; PROTEIN NOXA;

ADENOVIRUS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE HOMEOSTASIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; BONE AND BONES; HOMEOSTASIS; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-BCL-2;

ADENOVIRIDAE; MUS;

EID: 79960056564     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.040     Document Type: Article

References (32)

1. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 2007, 7:292-304.
2. Suda T., Takahasi N., Udagawa N., et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 1999, 20:345-357.
3. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 2003, 4:638-649.
4. Tanaka S., Miyazaki T., Fukuda A., et al. Molecular mechanism of the life and death of the osteoclast. Ann. N.Y. Acad. Sci. 2006, 1068:180-186.
5. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000, 21:115-137.
6. Xing L., Boyce B.F. Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem. Biophys. Res. Commun. 2005, 328:709-720.
7. Cotter T.G. Apoptosis and cancer: the genesis of a research field. Nat. Rev. Cancer 2009, 9:501-507.
8. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
9. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
10. Oda E., Ohki R., Murasawa H., et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
11. Ploner C., Kofler R., Villunger A. Noxa: at the tip of the balance between life and death. Oncogene 2009, 27:S84-S92.
12. Shibue T., Takeda K., Oda E., et al. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 2003, 17:2233-2238.
13. Wensveen F.M., Van Gisbergen K.P., Derks I.A., et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010, 32:754-765.
14. Nagase Y., Iwasawa M., Akiyama T., et al. Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J. Biol. Chem. 2009, 284:36659-36669.
15. Iwasawa M., Miyazaki T., Nagase Y., et al. The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. J. Clin. Invest. 2009, 119:3149-3159.
16. Akiyama T., Bouillet P., Miyazaki T., et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 2003, 22:6653-6664.
17. Nishikawa K., Nakashima T., Hayashi M., et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. USA 2010, 107:3117-3122.
18. Nishikawa K., Nakashima T., Takeda S., et al. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. J. Clin. Invest. 2010, 120:3455-3465.
19. Shinohara M., Koga T., Okamoto K., et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 2008, 132:794-806.
20. Sato K., Suematsu A., Nakashima T., et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 2006, 12:1410-1416.
21. Aliprantis A.O., Ueki Y., Sulyanto R., et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 2008, 118:3775-3789.
22. Tanaka S., Takahashi T., Takayanagi H., et al. Modulation of osteoclast function by adenovirus vector-induced epidermal growth factor receptor. J. Bone Miner. Res. 1998, 13:1714-1720.
23. Takayanagi H., Juji T., Miyazaki T., et al. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J. Clin. Invest. 1999, 104:137-146.
24. Hayashi M., Nakashima T., Kodama T., et al. Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation. Biochem. Biophys. Res. Commun. 2010, 393:432-438.
25. Takayanagi H., Kim S., Koga T., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
26. Takayanagi H., Ogasawara K., Hida S., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000, 408:600-605.
27. Nakamura T., Imai Y., Matsumoto T., et al. Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 2007, 130:811-823.
28. Hughes D.E., Dai A., Tiffee J.C., et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat. Med. 1996, 2:1132-1136.
29. McGill G.G., Horstmann M., Widlund H.R., et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002, 109:707-718.
30. Wang X., Kua H.Y., Hu Y., et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell. Biol. 2006, 172:115-125.
31. Aikawa T., Shinzawa K., Tanaka N., Tsujimoto Y. Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death. FEBS Lett. 2010, 584:681-688.
32. Michalak E.M., Villunger A., Adams J.M., Strasser A. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ. 2008, 15:1019-1029.